Antibodies.com
Latest round
- Seed
Last raised
- Feb 2019
Total raised
- $0.4M
Investors
- 1
About Antibodies.com
com Limited develops and distributes research products, particularly in the field of immunology.81 million post-money.com specializes in high-quality research products, focusing on primary and secondary antibodies, recombinant proteins, and ELISA kits.com generates revenue through direct sales of its research products to academic institutions, healthcare facilities, and biotechnology companies. Pricing is based on product complexity and discounts for new labs are available. The company is targeting expansion into European and Asia Pacific markets by 2025, focusing on increasing its portfolio of ELISA kits and recombinant proteins.
Who invested in Antibodies.com
1 investor across 1 round
See all investors in Antibodies.com
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 25, 2019
Amount
$0.4M
Investors
Questions about Antibodies.com
Who invested in Antibodies.com?
Antibodies.com has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antibodies.com raised?
Antibodies.com has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Antibodies.com last raise money?
Antibodies.com's most recent round on record is a Seed, in Feb 2019.
What does Antibodies.com do?
com Limited develops and distributes research products, particularly in the field of immunology.
Where is Antibodies.com headquartered?
Antibodies.com is headquartered in Cambridge, UK.
Which VCs invest in companies like Antibodies.com?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back internet companies at Antibodies.com's stage. Their profiles are linked below.
VCs backing internet startups at Seed
Raising like Antibodies.com? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.